Recap: BioLife Solutions Q2 Earnings

Shares of BioLife Solutions BLFS moved higher by 4.2% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 100.00% over the past year to ($0.00), which beat the estimate of ($0.07).

Revenue of $31,204,000 up by 214.56% year over year, which beat the estimate of $27,550,000.

Looking Ahead

BioLife Solutions hasn't issued any earnings guidance for the time being.

The upcoming fiscal year's revenue expected to be between $108,000,000 and $117,000,000.

Conference Call Details

Date: Aug 12, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/w4ueyrtd

Technicals

52-week high: $50.45

Company's 52-week low was at $18.20

Price action over last quarter: Up 61.60%

Company Overview

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!